Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Top Insider Trades 2/5/14: DRNA, RGLS, RARE, CARA

|Includes:CARA, Dicerna Pharmaceuticals, Inc. (DRNA), RARE, RGLS

Daily Top Insider Trades Instablog

  • Did you know? You could have seen the trades below within hours of being filed. If you want more Top Trades emailed 4 times a day, sign up for our Free Intra-Day Top Trades Alerts.

In a victory for common sense, the trading behavior of company executives, directors, and large shareholders in the stocks of firms they're registered "insiders" at have been proven profitable to monitor by both academic studies and (more importantly) the experience of professional investors.

Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Wednesday, February 5, 2014 as ranked by dollar value.

Please note, however, that these are factual lists (with edits to remove some noise), not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

We should also point out that we are presently in a slow filing time for insiders because many companies still have their trading windows closed to their executives until their June quarter earnings are released.

But at InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these regular blog posts as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to email support@insiderinsights.com with any questions on our proprietary insider data, and how it is best analyzed.

Insider Purchases
Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
Ra Capital Mgt PR,BO Dicerna Pharm DRNA JB* $15,000,000
Sanofi BO Regulus Therap RGLS JB* $9,999,993
FMR BO Ultragenyx Pharm RARE JB* $3,675,000
West Gary L BO West WSTC B $2,488,255
Rho Ventures Vi BO Cara Therapeutics CARA JB* $2,483,998
Marubeni DIR,BO Aircastle AYR B $554,604
Witte William A DIR New Home Co NWHM JB* $550,000
Johnson David D DIR Mts Systems MTSC B $352,050
Frost Phillip Md CEO,CB,BO Opko Health OPK B $330,645
Lagomarsino Simone CEO,DIR Heritage Oaks HEOP JB* $324,987
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

Insider Sales
Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
Brin Sergey F,DIR,BO Google GOOG AS $95,403,792
Sherman George CB,DIR Rexnord RXN JS* $26,546,699
John George H F,CEO,CB Rocket Fuel FUEL S $17,935,374
Hoffman Reid DIR,BO Linkedin LNKD AS $17,684,010
Avalon Ventures IX BO Aratana Therap PETX JS* $15,675,000
Shapiro David DIR Global Brass & Cop BRSS JS* $14,787,500
Meeusen Ronald L DIR Aratana Therap PETX JS* $9,500,000
Weiner Jeff CEO,DIR Linkedin LNKD AS $7,851,817
Link Max DIR Alexion Pharm ALXN S $6,206,220
Schwab Charles CB,DIR,BO Schwab Charles SCHW S $6,005,230
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

Stocks: DRNA, RGLS, RARE, CARA